Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04286529 · ClinicalTrials.gov registry record · Phase 1
Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons
A Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT04286529: Clinical Trial Phase 1 study, sponsored by Mayo Clinic.
NCT04286529 is a Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04286529, a Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this research is to study the effects of 1,25(OH)2 D3 (a prescription form of active Vitamin D) on muscle strength and insulin secretion by the pancreas and glucose utilization by skeletal muscle.
Interventions
- DRUG Oral Placebo
- DRUG Calcitriol capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-05-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04286529
The ClinicalTrials.gov registry entry for NCT04286529 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oral Placebo is the first listed.
NCT04286529 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04286529 about?
NCT04286529 is a clinical study titled "Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons". The purpose of this research is to study the effects of 1,25(OH)2 D3 (a prescription form of active Vitamin D) on muscle strength and insulin secretion by the pancreas and glucose utilization by skeletal muscle.
What is the current status of trial NCT04286529?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2020-10-01. Estimated completion is 2021-05-28.
What interventions are being tested in trial NCT04286529?
The interventions under investigation include: Oral Placebo (DRUG), Calcitriol capsules (DRUG).
Who is sponsoring clinical trial NCT04286529?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.